Mathew J, Cherukuri SV, Dihowm F. SARS-CoV-2 with concurrent coccidioidomycosis complicated by refractory pneumothorax in a Hispanic male: A case report and literature review. World J Respirol 2021; 11(1): 1-11 [DOI: 10.5320/wjr.v11.i1.1]
Corresponding Author of This Article
Joscilin Mathew, MBBS, MD, Doctor, Department of Internal Medicine, Texas Tech University Health Sciences Center El Paso, 4800 Alberta Ave. MSC 41007, El Paso, TX 79905, United States. joscilin.mathew@gmail.com
Research Domain of This Article
Medicine, General & Internal
Article-Type of This Article
Case Report
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Respirol. Aug 8, 2021; 11(1): 1-11 Published online Aug 8, 2021. doi: 10.5320/wjr.v11.i1.1
SARS-CoV-2 with concurrent coccidioidomycosis complicated by refractory pneumothorax in a Hispanic male: A case report and literature review
Joscilin Mathew, Sundar V Cherukuri, Fatma Dihowm
Joscilin Mathew, Sundar V Cherukuri, Fatma Dihowm, Department of Internal Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, TX 79905, United States
Author contributions: Cherukuri S and Dihowm F participated in the direct medical care described in this manuscript; Mathew J and Cherukuri SV contributed to the manuscript’s concept, design and drafting, the acquisition of data, and the analysis and interpretation of the data; Mathew J, Cherukuri SV, and Dihowm F were responsible for the revision of the manuscript for important intellectual content.
Informed consent statement: Informed consent for surgical procedures performed were obtained.
Conflict-of-interest statement: The authors have no conflicts of interest to declare.
CARE Checklist (2016) statement: The manuscript was revised according to the CARE Checklist.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Joscilin Mathew, MBBS, MD, Doctor, Department of Internal Medicine, Texas Tech University Health Sciences Center El Paso, 4800 Alberta Ave. MSC 41007, El Paso, TX 79905, United States. joscilin.mathew@gmail.com
Received: March 17, 2021 Peer-review started: March 17, 2021 First decision: March 31, 2021 Revised: April 14, 2021 Accepted: July 9, 2021 Article in press: July 9, 2021 Published online: August 8, 2021 Processing time: 139 Days and 4.3 Hours
Core Tip
Core Tip: This case highlights the presence of a concomitant infection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coccidioidomycosis. This was further complicated by the formation of a refractory pneumothorax. Fungal infections in SARS-CoV-2 patients appear underdiagnosed and may have an increased prevalence in patients with comorbidities, such as malignancies, diabetes, and chronic lung disorders. Total 39 case reports were included in our literature review. The risk of pneumothorax and pneumomediastinum formation does not necessarily increase from a history of smoking or underlying lung pathology; however, the incidence of a prolonged cough prior to pneumothorax formation seems to be consistent across several reported cases.
